Brad Gallagher, Health Care Controversies Team co-leader, was interviewed by Pharma IQ in “Strengthening Cybersecurity in the Pharmaceutical Industry,” regarding how pharmaceutical companies can balance innovation with robust cybersecurity.
With rapid digital transformation occurring worldwide, especially in the health care industries, balancing innovation and data security may seem imposing for many companies. Brad explained that doing so requires a strong framework, partnering with specialists, and regular training.
Brad also discussed how, while recent regulations and laws have increased security, data breaches and other threats are still omnipresent due to outdated systems and lack of preparedness. AI systems and medical devices are particularly vulnerable to cyberattacks, but incorporating security in their initial design may help protect against these threats, Brad said.
“These technological advances are going to help lead the next wave of prevention, detection, and response,” Brad said. “They will hopefully make it harder for attackers to be successful; however, the counterpoint is that they also may result in more sophisticated attacks as well.”
Click here to read the full article.